IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,815 | -24.0% | 13,366 | +17.6% | 0.00% | -25.0% |
| Q2 2023 | $80,038 | +37.4% | 11,369 | +24.7% | 0.00% | +33.3% |
| Q4 2022 | $58,270 | -33.3% | 9,119 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $87,360 | -13.2% | 9,119 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $100,674 | +3.8% | 9,119 | +79.4% | 0.00% | +300.0% |
| Q4 2021 | $97,015 | -21.9% | 5,082 | +0.8% | 0.00% | -50.0% |
| Q3 2021 | $124,286 | -60.8% | 5,040 | -49.7% | 0.00% | -60.0% |
| Q1 2021 | $317,012 | -34.7% | 10,013 | -4.3% | 0.01% | -28.6% |
| Q4 2020 | $485,530 | +38.3% | 10,464 | -1.9% | 0.01% | +16.7% |
| Q3 2020 | $351,191 | +19.1% | 10,668 | -0.7% | 0.01% | +20.0% |
| Q2 2020 | $294,950 | -72.2% | 10,745 | -69.7% | 0.01% | -78.3% |
| Q1 2020 | $1,061,615 | +4.9% | 35,464 | -3.0% | 0.02% | +35.3% |
| Q4 2019 | $1,011,925 | +49.3% | 36,558 | -1.8% | 0.02% | +54.5% |
| Q3 2019 | $677,768 | -21.9% | 37,240 | +5.2% | 0.01% | -26.7% |
| Q2 2019 | $867,640 | +157.8% | 35,385 | 0.0% | 0.02% | +150.0% |
| Q1 2019 | $336,511 | +7.5% | 35,385 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $313,157 | +1.7% | 35,385 | +29.3% | 0.01% | +20.0% |
| Q3 2018 | $307,969 | – | 27,375 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |